Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 146

1.

Diurnal Differences in Risk of Cardiac Arrhythmias During Spontaneous Hypoglycemia in Young People With Type 1 Diabetes.

Novodvorsky P, Bernjak A, Chow E, Iqbal A, Sellors L, Williams S, Fawdry RA, Parekh B, Jacques RM, Marques JL, Sheridan PJ, Heller SR.

Diabetes Care. 2017 Feb 17. pii: dc162177. doi: 10.2337/dc16-2177. [Epub ahead of print]

PMID:
28213374
2.

Cardiac Autonomic Regulation and Repolarization During Acute Experimental Hypoglycemia in Type 2 Diabetes.

Chow E, Bernjak A, Walkinshaw E, Lubina-Solomon A, Freeman J, Macdonald IA, Sheridan PJ, Heller SR.

Diabetes. 2017 Jan 30. pii: db161310. doi: 10.2337/db16-1310. [Epub ahead of print]

PMID:
28137792
3.

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndromes: the EXAMINE trial.

Heller SR, Bergenstal RM, White WB, Kupfer S, Bakris GL, Cushman WC, Mehta CR, Nissen SE, Wilson CA, Zannad F, Liu Y, Gourlie NM, Cannon CP; EXAMINE Investigators..

Diabetes Obes Metab. 2017 Jan 6. doi: 10.1111/dom.12871. [Epub ahead of print]

PMID:
28058763
4.

A systematic review of interventions to improve outcomes for young adults with Type 1 diabetes.

O'Hara MC, Hynes L, O'Donnell M, Nery N, Byrne M, Heller SR, Dinneen SF; Irish Type 1 Diabetes Young Adult Study Group..

Diabet Med. 2016 Oct 20. doi: 10.1111/dme.13276. [Epub ahead of print] Review.

PMID:
27761951
5.

Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.

White WB, Kupfer S, Zannad F, Mehta CR, Wilson CA, Lei L, Bakris GL, Nissen SE, Cushman WC, Heller SR, Bergenstal RM, Fleck PR, Cannon CP; EXAMINE Investigators..

Diabetes Care. 2016 Jul;39(7):1267-73. doi: 10.2337/dc16-0303.

PMID:
27289121
6.

Low-Blood Glucose Avoidance Training Improves Glycemic Variability in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: HypoCOMPaSS Trial.

Tan HK, Little SA, Leelarathna L, Walkinshaw E, Lubina-Solomon A, Hosking J, Speight J, Kerr D, Heller SR, Evans ML, Shaw JA, Flanagan D.

Diabetes Care. 2016 Apr;39(4):e56-8. doi: 10.2337/dc15-2431. No abstract available.

PMID:
26953169
7.

Blood glucose monitoring had no impact on distress or self-efficacy in people with non-insulin-treated type 2 diabetes.

Heller SR.

Evid Based Med. 2016 Feb;21(1):20. doi: 10.1136/ebmed-2015-110279. No abstract available.

PMID:
26526194
8.

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.

Tauschmann M, Thabit H, Leelarathna L, Elleri D, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2015 Oct 7;9(6):1346-7. doi: 10.1177/1932296815604439. No abstract available.

9.

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.

Thabit H, Leelarathna L, Wilinska ME, Elleri D, Allen JM, Lubina-Solomon A, Walkinshaw E, Stadler M, Choudhary P, Mader JK, Dellweg S, Benesch C, Pieber TR, Arnolds S, Heller SR, Amiel SA, Dunger D, Evans ML, Hovorka R.

Diabetes Technol Ther. 2015 Nov;17(11):801-7. doi: 10.1089/dia.2015.0062.

10.

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.

Heller SR, Frier BM, Hersløv ML, Gundgaard J, Gough SC.

Diabet Med. 2016 Apr;33(4):471-7. doi: 10.1111/dme.12844.

11.

Explaining engagement in self-monitoring among participants of the DESMOND Self-monitoring Trial: a qualitative interview study.

Eborall HC, Dallosso HM, McNicol S, Speight J, Khunti K, Davies MJ, Heller SR.

Fam Pract. 2015 Oct;32(5):596-602. doi: 10.1093/fampra/cmv060.

PMID:
26160892
12.

An observational study of patient characteristics and mortality following hypoglycemia in the community.

Elwen FR, Huskinson A, Clapham L, Bottomley MJ, Heller SR, James C, Abbas A, Baxter P, Ajjan RA.

BMJ Open Diabetes Res Care. 2015 Jun 30;3(1):e000094. doi: 10.1136/bmjdrc-2015-000094.

13.

InChI, the IUPAC International Chemical Identifier.

Heller SR, McNaught A, Pletnev I, Stein S, Tchekhovskoi D.

J Cheminform. 2015 May 30;7:23. doi: 10.1186/s13321-015-0068-4.

14.

Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q).

Speight J, Barendse SM, Singh H, Little SA, Inkster B, Frier BM, Heller SR, Rutter MK, Shaw JA.

Diabet Med. 2016 Mar;33(3):376-85. doi: 10.1111/dme.12824.

PMID:
26042777
15.

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.

Pieber TR, Deller S, Korsatko S, Jensen L, Christiansen E, Madsen J, Heller SR.

Diabetes Obes Metab. 2015 Aug;17(8):742-50. doi: 10.1111/dom.12473.

PMID:
25855340
16.

Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.

Young AJ, Thabit H, Heller SR, Evans ML, Amiel SA, Hovorka R, Barnard KD.

J Diabetes Sci Technol. 2015 Jul;9(4):932-3. doi: 10.1177/1932296815580162. No abstract available.

17.

Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.

Thabit H, Elleri D, Leelarathna L, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Barnard KD, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2015 May;17(5):452-8. doi: 10.1111/dom.12427.

18.

Response to comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122.

Little SA, Leelarathna L, Walkinshaw E, Tan HK, Chapple O, Lubina-Solomon A, Chadwick TJ, Barendse S, Stocken DD, Brennand C, Marshall SM, Wood R, Speight J, Kerr D, Flanagan D, Heller SR, Evans ML, Shaw JA.

Diabetes Care. 2014 Dec;37(12):e272-3. doi: 10.2337/dc14-1947. No abstract available.

PMID:
25414405
19.

A cluster randomized controlled non-inferiority trial of 5-day Dose Adjustment for Normal Eating (DAFNE) training delivered over 1 week versus 5-day DAFNE training delivered over 5 weeks: the DAFNE 5 × 1-day trial.

Elliott J, Rankin D, Jacques RM, Lawton J, Emery CJ, Campbell MJ, Dixon S, Heller SR; NIHR DAFNE Research Study Group..

Diabet Med. 2015 Mar;32(3):391-8. doi: 10.1111/dme.12621.

PMID:
25363466
20.

Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.

Thabit H, Lubina-Solomon A, Stadler M, Leelarathna L, Walkinshaw E, Pernet A, Allen JM, Iqbal A, Choudhary P, Kumareswaran K, Nodale M, Nisbet C, Wilinska ME, Barnard KD, Dunger DB, Heller SR, Amiel SA, Evans ML, Hovorka R.

Lancet Diabetes Endocrinol. 2014 Sep;2(9):701-9. doi: 10.1016/S2213-8587(14)70114-7.

Items per page

Supplemental Content

Loading ...
Support Center